Is a regenerative therapy product developed by Amnio Technology, designed to utilize the connective tissue matrix for homologous purposes, providing support and filling spaces. It contains natural elements from placental tissues, such as growth factors, cytokines, amino acids, extracellular matrix proteins and hyaluronic acid.

Donor tissues are sourced in the United States through qualified recovery partners, following strict selection and recovery protocols. All products are aseptically processed according to current Good Tissue Practice (cGTP) and Good Manufacturing Practice (cGMP) standards. GrowFX® is available in various volumes and can be administered topically or implanted according to clinical preference. It is terminally sterilized by E-Beam irradiation and can be stored long-term at room temperature (15-30°C).